Electromagnetic-Guided MLC Tracking Radiation Therapy for Prostate Cancer Patients: Prospective Clinical Trial Results

被引:21
作者
Keall, Paul J. [1 ]
Colvill, Emma [1 ,2 ]
O'Brien, Ricky [1 ]
Caillet, Vincent [1 ,2 ]
Eade, Thomas [2 ]
Kneebone, Andrew [2 ]
Hruby, George [2 ]
Poulsen, Per R. [3 ]
Zwan, Benjamin [4 ,5 ]
Greer, Peter B. [4 ,6 ]
Booth, Jeremy [1 ,2 ]
机构
[1] Univ Sydney, ACRF Image Inst X, Biomed Bldg,C81 Camperdown, Sydney, NSW 2006, Australia
[2] Royal North Shore Hosp, Northern Sydney Canc Ctr, Sydney, NSW, Australia
[3] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
[4] Univ Newcastle, Sch Math & Phys Sci, Newcastle, NSW, Australia
[5] Cent Coast Canc Ctr, Gosford, Australia
[6] Calvary Mater Newcastle, Newcastle, NSW, Australia
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 101卷 / 02期
基金
澳大利亚国家健康与医学研究理事会;
关键词
MULTILEAF COLLIMATOR TRACKING; MOVING TARGETS; MOTION; RADIOTHERAPY; MANAGEMENT; ACCURACY; DELIVERY; SYSTEM; GLAND;
D O I
10.1016/j.ijrobp.2018.01.098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To report on the primary and secondary outcomes of a prospective clinical trial of electromagnetic-guided multileaf collimator (MLC) tracking radiation therapy for prostate cancer. Methods and Materials: Twenty-eight men with prostate cancer were treated with electromagnetic-guided MLC tracking with volumetric modulated arc therapy. A total of 858 fractions were delivered, with the dose per fraction ranging from 2 to 13.75 Gy. The primary outcome was feasibility, with success determined if > 95% of fractions were successfully delivered. The secondary outcomes were (1) the improvement in beam-target geometric alignment, (2) the improvement in dosimetric coverage of the prostate and avoidance of critical structures, and (3) no acute grade >= 3 genitourinary or gastrointestinal toxicity. Results: All 858 planned fractions were successfully delivered with MLC tracking, demonstrating the primary outcome of feasibility (P<.001). MLC tracking improved the beam-target geometric alignment from 1.4 to 0.90 mm (root-mean-square error). MLC tracking improved the dosimetric coverage of the prostate and reduced the daily variation in dose to critical structures. No acute grade >= 3 genitourinary or gastrointestinal toxicity was observed. Conclusions: Electromagnetic-guided MLC tracking radiation therapy for prostate cancer is feasible. The patients received improved geometric targeting and delivered dose distributions that were closer to those planned than they would have received without electromagnetic-guided MLC tracking. No significant acute toxicity was observed. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 395
页数:9
相关论文
共 27 条
[1]   The Dosimetric Impact of Prostate Rotations During Electromagnetically Guided External-Beam Radiation Therapy [J].
Amro, Hanan ;
Hamstra, Daniel A. ;
Mcshan, Daniel L. ;
Sandler, Howard ;
Vineberg, Karen ;
Hadley, Scott ;
Litzenberg, Dale .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01) :230-236
[2]   DMLC tracking and gating can improve dose coverage for prostate VMAT [J].
Colvill, E. ;
Poulsen, P. R. ;
Booth, J. T. ;
O'Brien, R. T. ;
Ng, J. A. ;
Keall, P. J. .
MEDICAL PHYSICS, 2014, 41 (09)
[3]   Multileaf Collimator Tracking Improves Dose Delivery for Prostate Cancer Radiation Therapy: Results of the First Clinical Trial [J].
Colvill, Emma ;
Booth, Jeremy T. ;
O'Brien, Ricky T. ;
Eade, Thomas N. ;
Kneebone, Andrew B. ;
Poulsen, Per R. ;
Keall, Paul J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (05) :1141-1147
[4]   A novel electron gun for inline MRI-linac configurations [J].
Constantin, Dragos E. ;
Holloway, Lois ;
Keall, Paul J. ;
Fahrig, Rebecca .
MEDICAL PHYSICS, 2014, 41 (02) :022301
[5]   Proof of concept of MRI-guided tracked radiation delivery: tracking one-dimensional motion [J].
Crijns, S. P. M. ;
Raaymakers, B. W. ;
Lagendijk, J. J. W. .
PHYSICS IN MEDICINE AND BIOLOGY, 2012, 57 (23) :7863-7872
[6]  
Dan Ruan, 2011, 2011 IEEE Power Engineering and Automation Conference (PEAM 2011), P100, DOI 10.1109/PEAM.2011.6135024
[7]   A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or 125I permanent implant [J].
Eade, Thomas N. ;
Horwitz, Eric M. ;
Ruth, Karen ;
Buyyounouski, Mark K. ;
D'Ambrosio, David J. ;
Feigenberg, Steven J. ;
Chen, David Y. T. ;
Pollack, Alan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (02) :338-345
[8]   Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy [J].
Eade, Thomas N. ;
Guo, Linxin ;
Forde, Elizabeth ;
Vaux, Ken ;
Vass, Justin ;
Hunt, Peter ;
Kneebone, Andrew .
BJU INTERNATIONAL, 2012, 109 (11) :1655-1660
[9]   Dynamic tumor tracking using the Elekta Agility MLC [J].
Fast, Martin F. ;
Nill, Simeon ;
Bedford, James L. ;
Oelfke, Uwe .
MEDICAL PHYSICS, 2014, 41 (11)
[10]   Toward the development of intrafraction tumor deformation tracking using a dynamic multi-leaf collimator [J].
Ge, Yuanyuan ;
O'Brien, Ricky T. ;
Shieh, Chun-Chien ;
Booth, Jeremy T. ;
Keall, Paul J. .
MEDICAL PHYSICS, 2014, 41 (06)